Jacques Maas: Transformative Strategies for Endometriosis and Adenomyosis
Jacques Maas, Head Center for Reproductive Medicine at Maastricht UMC+, shared a post on LinkedIn:
“When two research schools of Maastricht University Faculty of Health, Medicine and Life Sciences and Maastricht UMC+: MERLN Institute for Technology-Inspired Regenerative Medicine and GROW – Research Institute for Oncology and Reproduction find each other and utilize long-standing, fruitful collaborations in the Netherlands in the field of endometriosis and adenomyosis, the impossible apparently becomes possible.
Roman Truckenmüller, Paul Wieringa, Niloofar Tahmasebi, and Erik Vrij have been awarded the prestigious NWO (Dutch Research Council) Perspective Grant for the project ‘FEMCHIP – Tackling endometriosis and adenomyosis through improved clinical diagnostics and human in vitro models to unlock understanding and therapy development’.
FEMCHIP aims to transform the diagnosis and treatment of endometriosis and adenomyosis by developing innovative imaging tools, creating advanced 3D disease models, and identifying new therapies to reduce pain and improve fertility.
The FEMCHIP consortium is a collaboration between Maastricht University, MUMC+, UMC Utrecht, Amsterdam UMC, and Radboud University. To address the urgent need for better diagnostics and treatments, FEMCHIP collaborates closely with Dutch and international industry partners, patient organizations, and innovation hubs to accelerate solutions for these underserved diseases.
Programme lead: prof. dr. Roman K. Truckenmüller
Co-applicants: dr. ir. P.A.W. Wieringa, dr. ir. E.J. Vrij, dr. Z.N. Tahmasebi Birgani, Jacques Maas, Salwan Al-Nasiry, Andrea Romano, Velja Mijatovic, Judith Huirne, Arjan W. Griffioen, Lynda Juffermans, Bernadette de Bakker, Lennie Van Hanegem, Willem Verpoest, Gaby Steba, Klaas Mulder, prof. dr. M. Vermeulen
Consortium: Endometriose Stichting, Genomics, 300MICRONS GmbH, chiron, CimCure B.V., Fluidnatek and Spinbox by Bioinicia, ibidi GmbH, Little Miracles Foundation, Merck Group, Metatissue, Olink, Optics11 Life, Proefdiervrij, ReGEN Biomedical, Samsung Healthcare, STEMCELL Technologies, Theramex, TNO, and Topigs Norsvin”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Jan 12, 2026, 16:03New Insights Into Estrogen Receptor Alpha Regulation in the Endometrium – Fertility and Sterility
-
Jan 12, 2026, 15:37From Innovation to Practice: Standards for Embryo Diagnostic Trials – Fertility and Sterility
-
Jan 12, 2026, 14:47HFEA Updates Choose a Fertility Clinic Tool to Improve Success Reporting
-
Jan 12, 2026, 13:14Lucile Ferreux: Prenatal Cadmium Exposure and Its Long-Term Impact on Male Fertility
-
Jan 12, 2026, 13:11This Month’s Fertility and Sterility Unplugged Is Live – Fertility and Sterility
-
Jan 11, 2026, 10:02Hind Hanani: Understanding the Use of Antiphospholipid Syndrome Guidelines Worldwide
-
Jan 11, 2026, 09:58Exploring the Role of Antiphospholipid Antibodies in Severe Preeclampsia – RheumNow
-
Jan 11, 2026, 09:56Adrenal Involvement in Antiphospholipid Syndrome – ARP Rheumatology
-
Jan 11, 2026, 09:52Jamie Agunsday: Understanding Pregnancy-Related Deaths